When Large Language Models Fail in Healthcare: Evaluating Sensitivity to Prompt Variations
A systematic robustness evaluation reveals that both general-purpose and medical-specialized LLMs fail catastrophically under minor prompt rewording, undermining their deployment in clinical settings where consistency is non-negotiable. The study exposes a critical gap between benchmark performance and real-world reliability, suggesting that domain-specific training alone does not confer the adversarial resilience required for safety-critical applications. This finding reshapes expectations around LLM readiness for regulated healthcare workflows and signals that prompt engineering and model hardening must precede clinical adoption.
Modelwire context
ExplainerThe buried finding here is that specialized models like BioLlama3 and ClinicalBERT performed no more robustly than general-purpose counterparts under prompt perturbation, which directly challenges the assumption that domain fine-tuning buys safety properties beyond factual accuracy. Benchmark scores and real-world consistency are measuring different things entirely.
This connects tightly to two threads we have been tracking. The eating disorder study from June 1 ('Food Noise and False Safety') showed that specific linguistic patterns in user prompts trigger unsafe outputs, which is essentially the same fragility mechanism described here, just in a different clinical domain. The ClinEnv benchmark piece from the same week made a parallel argument from the evaluation side: that static multiple-choice benchmarks cannot capture how models behave under realistic clinical conditions. Together, these three papers form a coherent indictment of how the field currently validates LLMs for healthcare, where surface performance masks structural brittleness.
Watch whether any of the model developers named in this study, particularly Meta given BioLlama3's inclusion, respond with targeted robustness fine-tuning or revised clinical guidance within the next two quarters. If they do not, regulatory bodies like the FDA's Digital Health Center will likely cite papers like this when tightening software-as-a-medical-device review criteria.
This analysis is generated by Modelwire’s editorial layer from our archive and the summary above. It is not a substitute for the original reporting. How we write it.
MentionsGPT-3.5 · Llama3 · ClinicalBERT · BioLlama3 · BioBERT · MedMCQA
Modelwire Editorial
This synthesis and analysis was prepared by the Modelwire editorial team. We use advanced language models to read, ground, and connect the day’s most significant AI developments, providing original strategic context that helps practitioners and leaders stay ahead of the frontier.
Modelwire summarizes, we don’t republish. The full content lives on arxiv.org. If you’re a publisher and want a different summarization policy for your work, see our takedown page.